SLVRX
Price
$35.50
Change
+$0.23 (+0.65%)
Updated
Jul 3 closing price
Net Assets
2.4B
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

SLVRX vs VIVIX

Header iconSLVRX vs VIVIX Comparison
Open Charts SLVRX vs VIVIXBanner chart's image
Columbia Select Large Cap Value R
Price$35.50
Change+$0.23 (+0.65%)
VolumeN/A
Net Assets2.4B
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
SLVRX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SLVRX vs. VIVIX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLVRX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. SLVRX (2.4B). VIVIX pays higher dividends than SLVRX: VIVIX (2.19) vs SLVRX (1.38). SLVRX was incepted earlier than VIVIX: SLVRX (22 years) vs VIVIX (27 years). SLVRX (1.33) is less costly to investors than VIVIX (0.04). SLVRX is a more actively managed with annual turnover of: 20.00 vs. VIVIX (9.00). SLVRX has a lower initial minimum investment than VIVIX: SLVRX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 11.41 vs. SLVRX (10.49). VIVIX return over 5 years is better than : 79.11 vs. SLVRX (72.93).
SLVRXVIVIXSLVRX / VIVIX
Total Expense Ratio1.050.042,625%
Annual Report Gross Expense Ratio1.330.043,325%
Fund Existence22 years27 years-
Gain YTD9.1955.609164%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B189B1%
Annual Yield % from dividends1.382.1963%
Returns for 1 year10.4911.4192%
Returns for 3 years36.3234.40106%
Returns for 5 years72.9379.1192%
Returns for 10 years69.73114.4561%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KB85.701.60
+1.90%
KB Financial Group
BNL16.340.14
+0.86%
Broadstone Net Lease
EYPT9.720.06
+0.62%
EyePoint Pharmaceuticals
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc